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Abstract
Background: Cluster randomization design is increasingly used for the evaluation of health-care,
screening or educational interventions. The intraclass correlation coefficient (ICC) defines the
clustering effect and be specified during planning. The aim of this work is to study the influence of
the ICC on power in cluster randomized trials.
Methods: Power contour graphs were drawn to illustrate the loss in power induced by an
underestimation of the ICC when planning trials. We also derived the maximum achievable power
given a specified ICC.
Results: The magnitude of the ICC can have a major impact on power, and with low numbers of
clusters, 80% power may not be achievable.
Conclusion: Underestimating the ICC during planning cluster randomized trials can lead to a
seriously underpowered trial. Publication of a priori postulated and a posteriori estimated ICCs is
necessary for a more objective reading: negative trial results may be the consequence of a loss of
power due to a mis-specification of the ICC.
Background
A cluster randomized trial involves randomizing social
units or clusters of individuals, rather than the individuals
themselves. This design, which is increasingly used for
evaluating health-care, screening and educational inter-
ventions [1-3], presents specific constraints that must be
considered during planning and analysis [4,5].
The responses of individuals within a cluster tend to be
more similar than those of individuals of different clus-
ters. This correlation leads to an increased required sam-
ple size in randomized trials of clusters compared with
that of individuals, although this clustering effect is rarely
taken into account. Thus, in a recent review of cluster ran-
domized trials in primary care, Eldridge et al [6] reported
that only 20% of studies accounted for clustering in the
sample size calculation. Similar results were found in
other reviews, as listed by Bland [7]. The increase in sam-
ple size is measured through an inflation factor, which is
a function of both the cluster size and the intraclass corre-
lation coefficient (ICC), which appraises the correlation
between individuals within the same cluster [1-3,8].
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Therefore an a priori value for this correlation must be pos-
tulated during planning. However, estimates of this corre-
lation are rarely available, and, if available, are often
uncertain. Indeed the correlation would differ according
to outcome, setting, intervention, covariate adjustment
and also sampling [5,9,10]. Therefore, a discrepancy
between a priori postulated and a posteriori estimated ICCs
may occur.
The discrepancy between a priori postulated and a posteri-
ori estimated ICCs may be reduced by intermediate esti-
mation of the ICC, thus allowing a re-estimation of the
required sample size [11]. However, the room to manœu-
vre to increase the sample size may be restricted. Indeed,
including new clusters may be difficult, either because the
number of clusters is limited [10,12-15] (which may
occur when the randomization unit is defined by a geo-
graphic area or hospital, for example) or because clusters
are frequently randomized all at once and not one at a
time. The cluster size itself may also be limited (e.g., by
the size of a family or because the number of patients fol-
lowed up in a clinical practice cannot be increased [16]),
which then disallows the increase in sample size by
increasing cluster size.
The purpose of our study was to assess the consequence
on power of the ICC and to what extent the discrepancy
between a priori postulated and a posteriori estimated ICCs
may induce a loss in power in cluster randomized trials.
Methods
We considered a completely cluster randomized design
with a continuous outcome (normally distributed) meas-
ured at a single time point. We assumed an equal number
of clusters randomized to each arm and a fixed common
cluster size. The sample size is calculated as follows [1]:
where m is the cluster size, g is the number of clusters per
arm, ρ is the ICC, ES is the effect size (defined as ratio
between the absolute difference between the two inter-
vention-specific means (|∆|) and the standard deviation
(σ)) and z1-α/2 and z1-β are the critical values of the stand-
ard normal distribution corresponding to error rates α
(two-sided) and β, respectively. One recognizes the sam-
ple size calculation for an individually randomized trial
inflated by a factor equal to [1 + (m - 1)ρ] defined as the
variance inflation factor. When the cluster size varies, m
refers to the average cluster size.
Power contour graphs
To quantify the influence of the ICC on the power, we
drew two kinds of power contour graphs. First, consider-
ing an effect size and an a priori postulated ICC, we con-
sidered several combinations of numbers of clusters and
cluster sizes that allow for achieving 80% power. Then
considering these combinations, we plotted the real
power as a function of the ICC, which may differ from the
a priori postulated value. Two values of a priori postulated
ICC (0.005, 0.02) and five numbers of clusters per inter-
vention arm (3, 5, 10, 20 and 40) were considered for
these graphs. The effect size was fixed at 0.25.
We also drew power contour graphs, showing combina-
tions of cluster sizes and number of clusters leading to a
pre-specified power, with type I error fixed at 5%. Four
power levels were considered (90, 80, 60 and 40%), 3
effect sizes (0.25, 0.50 and 0.75) and 4 levels of ρ (0.005,
0.020, 0.050 and 0.100). These ICC values were chosen
according to previously published estimates [3,6,12,16-
23].
Maximal theoretical achievable power
We determined the maximal achievable power given a
limited number of randomized clusters (i.e., considering
an infinite cluster size) or a limited cluster size (i.e., con-
sidering an infinite number of clusters). For a limited
number of clusters, results were graphically illustrated by
considering 5 numbers of clusters per intervention arm (3,
5, 10, 20 and 40) for 2 effect sizes (0.25, 0.5).
Results
Influence of the discrepancy between a priori postulated 
and a posteriori estimated ICCs on power
Figure 1 displays the real power associated with a study
whose a posteriori estimated ICC would differ from the a
priori postulated one. With an a priori ICC of 0.02, as few
as 5 clusters per intervention arm is not enough to achieve
a power of 80% to detect an effect size of 0.25. Power
decreases as the ICC increases, and the loss is all the more
important when the number of clusters is small. For
example, if the a priori ICC was fixed at 0.005 and the a
posteriori ICC is as high as 0.01, the power falls to 70.8%
with 5 clusters per intervention arm, instead of the tar-
geted 80% power, whereas the power is almost safe-
guarded with 20 clusters per intervention arm (real power
77.7%).
Figure 2 displays power contour graphs for combinations
of numbers of clusters and cluster sizes. First, let us con-
sider the situation of a fixed number of clusters. In many
situations, even a slight increase in the ICC has a great
influence on power and leads to a major increase in the
required cluster size to keep the desired power. In some
situations, even reaching the required power may no
longer be possible: the power contour curves tend to be
infinite. For instance, assuming that 15 clusters are rand-
omized to each arm and we want to detect an effect size of
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0.25 with 80% power, we would need an average cluster
size of 25 patients with an a priori ICC fixed at 0.02. To
keep 80% power, the required mean cluster size should be
increased to 98 for an ICC of 0.05, which represents 1095
more subjects per arm. If the ICC actually equals 0.10,
80% power is no longer achievable without recruiting
additional clusters. The phenomenon is all the more acute
when the number of fixed clusters is low.
Second, when the mean cluster size is limited but the
number of clusters is not, an increase in the ICC may also
be of great consequence. As an example, considering a
mean cluster size of 100, we would need to randomize 8
clusters per arm to detect a 0.25 effect size with 80%
power when the ICC is fixed at 0.02. This number of clus-
ters is raised to 15 and 28 when the ICC is fixed at 0.05
and 0.10, respectively, or 700 and 2000 additional sub-
jects, respectively, per arm.
Maximal theoretical power with infinite cluster size
In a cluster randomized trial aimed at detecting an effect
size ES at a pre-specified α level with an a priori postulated
ICC equal to ρ, changing the cluster size m and/or the
number of clusters g per group changes β and therefore
power. Power is thus related to the f(m, g) = (z1-α/2 + z1-β)2
function defined as
When m, the mean cluster size, tends to be infinite, f(m, g)
tends to be an asymptotic value, but there is no limit when
g, the number of clusters, is infinite:
Therefore, although power is not theoretically limited
when the number of clusters can be increased, a maximal
reachable power is possible when this number is fixed and
only the cluster size can be increased. This maximum the-
oretical power is defined as:
where  Φ-1( ) refers to the inverse cumulative function
associated with the standard normal distribution. This
maximal theoretical power decreases when the ICC
increases and/or the number of clusters decreases (Figure
3). In some cases, an 80% or 90% power is not achievable
even with a theoretical situation of infinite cluster sizes.
Real power of cluster randomized trials according to the discrepancy between the a priori postulated and a posteriori estimated  intraclass correlation coefficients Figure 1
Real power of cluster randomized trials according to the discrepancy between the a priori postulated and a posteriori estimated 
intraclass correlation coefficients. The effect size to be detected is fixed at 0.25 and power at 80%. g is the number of clusters 
per arm, m is the average cluster size and N is the total number per intervention arm considering an a priori postulated ICC of 
0.005 or 0.02.
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Power contour graphs for several intraclass correlation coefficients (ICCs) and effect sizes* Figure 2
Power contour graphs for several intraclass correlation coefficients (ICCs) and effect sizes*. Effect size is presented in columns 
and ICC in rows. In situations above or to the right of the red curve, the statistical power is greater than 90%. In situations 
between the red and blue curves, the statistical power is between 80% and 90%. In situations between the blue and red curves, 
the statistical power is between 60% and 80%. For vertical curves, increasing the cluster size is pointless. The number of sub-
jects required, assuming individual randomization, is 24 to achieve a power of 40% to detect an effect size of 0.50, and 38, 28, 
18 and 11 to achieve powers of 90%, 80%, 60% and 40%, respectively, to detect an effect size of 0.75, thus, the reason why 
curves are truncated. *Effect size = absolute difference between the two intervention-specific means divided by the S.D. of the 
response variable.BMC Medical Research Methodology 2005, 5:25 http://www.biomedcentral.com/1471-2288/5/25
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Thus, when 5 clusters are randomized to each arm, a
power of 80% to detect an effect size of 0.50 cannot be
achieved if the ICC is greater than 0.079 (and this limit
equals 0.058 when 90% power is considered). For an
effect size of 0.25, this upper ICC limit is 0.019 for 80%
power and 0.014 for 90% power.
Discussion
The ICC is a nuisance parameter that has to be a priori
specified when planning a cluster randomized trial. The
magnitude of this coefficient has a major impact on
power, particularly with a small number of randomized
clusters. Our results were derived considering a continu-
ous outcome, but in their simulation study, Donner and
Klar [24] showed that power never differs from more than
one percentage point in continuous or binary outcomes.
Moreover, we did not take into account any potential var-
iability in cluster size, which is already known to reduce
power [25]. When planning cluster randomized trials, var-
iability in cluster size is rarely taken into account, and the
cluster size m is generally replaced by the mean cluster
size. An underestimation of the ICC may therefore be
expected to have similar consequences when cluster size is
constant. In the end, an underestimation of the ICC dur-
ing planning could therefore lead to a severely underpow-
ered study and thus questionable results.
In cluster randomized trials, it is known that for a fixed
total number of subjects, the higher the number of clus-
ters (and thus the smaller the average cluster size), the
higher the power [2,4,5,14,24,26,27]. In the extreme case,
in clusters of size one, individuals are randomized, with
no loss of power because of correlation between subjects.
Moreover, it has also been shown that increasing cluster
size improves the power up to a certain threshold, which
depends on the value of the ICC [24,27]. Therefore, when
planning a cluster randomized trial, the optimal strategy
is indeed to randomize a large number of clusters
[1,2,12,29]. Such a strategy first allows for decreasing the
total sample size for a pre-specified power and second, as
our results show, protects against a loss of power induced
by an underestimation of the ICC when planning. How-
ever, because of logistic constraints, the number of rand-
omized clusters may be limited, and indeed, the review by
Eldridge et al [6] noted that half of the cluster randomized
trials analyzed had fewer than 29 clusters in each arm.
Therefore, for most cluster randomized trials, the a priori
postulated value of the ICC has a great impact on power.
When planning trials, the a priori postulated ICC will
rarely be very reliable. During the study, an intermediate
estimation of the ICC can be assessed, thus allowing a
sample size adjustment [11]. But the determination of this
intermediate estimation is not without error, as was
shown in the study by Moore et al [28], in which the inter-
mediate ICC was 0.012 and the final one 0.031. A sensi-
tivity analysis must therefore be undertaken when
planning, to account for uncertainty of the ICC. In the
Theoretical maximal power assuming an infinite cluster size for several fixed numbers of clusters according to two different  effect sizes * Figure 3
Theoretical maximal power assuming an infinite cluster size for several fixed numbers of clusters according to two different 
effect sizes *. *Effect size = absolute difference between the two intervention-specific means divided by the S.D. of the 
response variable.
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extreme situations, when very few clusters can be rand-
omized, such a sensitivity analysis may illustrate the high
risk of performing an underpowered study and thus high-
light arguments for not performing the study.
When reporting the study results, investigators should
publish both the ICC used during the planning and the a
posteriori  estimated one, as recommended initially by
some authors and recently by the extension of the CON-
SORT statement for cluster randomized trials [27,29-31].
However, such information is rarely available. We studied
cluster randomized trials published between January
2003 and December 2004 in the British Medical Journal,
"which contains more such reports than any other jour-
nal" [7], and the published extension of the CONSORT
statement [30]). Of 16 published studies, 5 (31.2%) did
not report an a priori postulated ICC and 2 reported no
sample size calculation. Only 5 (31.2%) reports provided
a posteriori estimated ICCs (without any confidence inter-
vals). Such under-reporting disallows assessing the dis-
crepancy between the a priori postulated ICC and the a
posteriori  estimated one. However, reporting both ICCs
would help readers "assess the appropriateness of the
original sample size calculations as well as the magnitude
of the clustering for each outcome" [30] and help investi-
gators design future trials [1,27,31]. It would also help
readers understand trial results, particularly negative ones:
a study may prove to be negative just by a loss of power
induced by an a priori underestimation of the ICC. On a
formal point, the publication format of the a posteriori
estimated ICC should follow the recommendation by
Campbell et al., who advocate specifying a description of
the data set and information on the method used to assess
it and the precision of the estimate [32].
In conclusion, our study supports modifications in inves-
tigators' practices when planning trials and reporting
results, taking into account the uncertainty of the ICC by
favoring a high number of clusters and publishing this
parameter. For readers, an objective reading of trial
results, particularly negative results, requires knowledge
of a priori and a posteriori estimated ICCs.
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